Screener

This page is a wide table. It works on a phone - the table scrolls sideways - but a laptop or a desktop shows many more columns at once.

Add columns 9 of 30

Click a figure to put it on the table; click a lit one to take it off again. Every column carries its own filters under its heading, and the arrows there move it left or right.

Company What the company is, where it trades, and how current our figures for it are.

Size & market How big it is and what the share price has done. Everything here needs a price.

Valuation What the market charges for a dollar of earnings, sales, book value or cash flow.

Profitability What share of revenue it keeps, and what it earns on the capital it uses.

Growth Change against the year before, and three-year compound rates.

Financial health Borrowings measured against the earnings, equity and assets that have to cover them.

Per share The same figures divided by the share count.

Income statement Amounts as reported on the income statement, latest full year.

Cash flow Amounts as reported on the cash flow statement, latest full year.

Balance sheet Amounts as reported on the balance sheet, at the latest year end.

Saved screens 0

Save the screener settings in the browser.

    Width
    Rows
    Reset all
    Filtering on Sector: Healthcare (remove)

    1,064 companies - showing 451-475

    Ticker
    Company
    × › ↺ Our own rollup of SEC's SIC code, not GICS. See About the data.
    Sector
    ‹ × › Amounts take a suffix: 2B, 500M, 1.5T, 250K.
    Market cap
    ‹ × ›
    P/E
    ‹ × ›
    EV/EBITDA
    ‹ × › In percent: type 15 for 15%.
    Dividend yield
    ‹ × › In percent: type 15 for 15%.
    EPS growth
    ‹ × › In percent: type 15 for 15%.
    ROIC
    ‹ × › In percent: type 15 for 15%.
    ROE
    ‹ ×
    Net debt / EBITDA
    FENC FENNEC PHARMACEUTICALS INC. Healthcare $434.5M — — — — — -27,461.1% —
    DNA Ginkgo Bioworks Holdings, Inc. Healthcare $431.6M — — — — — -0.1% —
    CMPX Compass Therapeutics, Inc. Healthcare $428.6M — — — — — -33.8% —
    CARL CARLSMED, INC. Healthcare $425.9M — — — — -21.1% -30.0% —
    CLPT ClearPoint Neuro, Inc. Healthcare $425.8M — — — — -24.8% -91.1% —
    RCKT ROCKET PHARMACEUTICALS, INC. Healthcare $423.7M — — — — — -80.5% —
    SBC SBC Medical Group Holdings Inc Healthcare $423.7M 8.2x 4.3x — 4.2% 14.4% 20.5% -1.72
    SI SHOULDER INNOVATIONS, INC. Healthcare $423.0M — — — — -13.3% -28.7% —
    CGC Canopy Growth Corp Healthcare $411.5M — — — — — — —
    ENTA ENANTA PHARMACEUTICALS INC Healthcare $410.1M — — — — — -126.5% —
    CYH COMMUNITY HEALTH SYSTEMS INC Healthcare $407.5M 0.8x 7.1x — — 15.5% — 6.80
    GEVO Gevo, Inc. Healthcare $405.5M — 95.7x — — -2.5% -7.3% 16.35
    LXEO Lexeo Therapeutics, Inc. Healthcare $401.2M — — — — — -40.5% —
    XFOR X4 Pharmaceuticals, Inc Healthcare $400.6M — — — — -26.3% -42.5% —
    LRMR Larimar Therapeutics, Inc. Healthcare $397.9M — — — — — -212.2% —
    IRD Opus Genetics, Inc. Healthcare $388.5M — — — — -185.1% -323.1% —
    IPSC Century Therapeutics, Inc. Healthcare $382.1M — — — — — -6.0% —
    OFIX Orthofix Medical Inc. Healthcare $378.4M — — — — -10.6% -20.5% —
    TKNO Alpha Teknova, Inc. Healthcare $371.5M — — — — -16.4% -25.1% —
    AGEN AGENUS INC Healthcare $371.0M — — — — — — —
    PALI PALISADE BIO, INC. Healthcare $364.2M — — — — — -13.0% —
    DMAC DiaMedica Therapeutics Inc. Healthcare $364.0M — — — — — -58.4% —
    CATX Perspective Therapeutics, Inc. Healthcare $357.3M — — — — -43.0% -49.8% —
    QTTB Q32 Bio Inc. Healthcare $356.9M 5.0x 20.6x — — — 70.9% —
    LYEL Lyell Immunopharma, Inc. Healthcare $352.1M — — — — — -110.6% —